Published in J Korean Neurosurg Soc on October 24, 2016
Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol (1969) 6.86
Systems biology: Metabonomics. Nature (2008) 5.32
Single nucleotide polymorphisms of tissue inhibitor of metalloproteinase genes in familial moyamoya disease. Neurosurgery (2006) 2.29
Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial. Stroke (2014) 2.12
Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke (2007) 2.08
Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One (2011) 2.01
Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease: results of multicenter survey in Japan. Stroke (2007) 2.00
Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke (2006) 1.68
Incidence and clinical features of disease progression in adult moyamoya disease. Stroke (2005) 1.47
Age-specific eNOS polymorphisms in moyamoya disease. Childs Nerv Syst (2011) 1.46
Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology (2012) 1.42
Progression of unilateral moyamoya disease: A clinical series. Cerebrovasc Dis (2006) 1.40
Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article. J Neurosurg (2009) 1.35
Effect of direct arterial bypass on the prevention of future stroke in patients with the hemorrhagic variety of moyamoya disease. J Neurosurg (2000) 1.21
Association of thyroid autoantibodies with moyamoya-type cerebrovascular disease: a prospective study. Stroke (2009) 1.20
Incidence, prevalence, and survival of moyamoya disease in Korea: a nationwide, population-based study. Stroke (2014) 1.11
Progression of disease in unilateral moyamoya syndrome. Neurosurg Focus (2008) 1.10
High-throughput quantification of circulating metabolites improves prediction of subclinical atherosclerosis. Eur Heart J (2012) 1.09
The efficacy of bypass surgery for the patients with hemorrhagic moyamoya disease. Clin Neurol Neurosurg (1997) 1.08
Surgical therapy for adult moyamoya disease. Can surgical revascularization prevent the recurrence of intracerebral hemorrhage? Stroke (1996) 1.03
Elevation of CRABP-I in the cerebrospinal fluid of patients with Moyamoya disease. Stroke (2003) 0.98
Genetics and Biomarkers of Moyamoya Disease: Significance of RNF213 as a Susceptibility Gene. J Stroke (2014) 0.98
Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease. J Neurol Neurosurg Psychiatry (2009) 0.98
The natural history of moyamoya in a North American adult cohort. J Clin Neurosci (2012) 0.93
Concurrence of Graves' disease and dysplastic cerebral blood vessels of the moyamoya variety. Thyroid (1997) 0.93
Long-term outcome of superficial temporal artery-middle cerebral artery bypass for patients with moyamoya disease in the US. Neurosurg Focus (2008) 0.91
Evaluation of angiographic changes of the anterior choroidal and posterior communicating arteries for predicting cerebrovascular lesions in adult moyamoya disease. J Clin Neurosci (2011) 0.91
Long-term outcomes after combined revascularization surgery in adult moyamoya disease. Stroke (2014) 0.90
Long-term follow-up results in 142 adult patients with moyamoya disease according to management modality. Acta Neurochir (Wien) (2012) 0.89
Association of HLA-DR and -DQ Genes with Familial Moyamoya Disease in Koreans. J Korean Neurosurg Soc (2009) 0.88
Surgical treatment of moyamoya disease in adults: combined direct and indirect vs. indirect bypass surgery. Neurol Med Chir (Tokyo) (2012) 0.87
Epidemiology of moyamoya disease in Taiwan: a nationwide population-based study. Stroke (2014) 0.87
A case of Graves' diseases associated with intracranial moyamoya vessels and tubular stenosis of extracranial internal carotid arteries. J Formos Med Assoc (1994) 0.87
Clinical and angiographic features and stroke types in adult moyamoya disease. AJNR Am J Neuroradiol (2014) 0.86
Prevalence and epidemiological features of moyamoya disease in Korea. J Cerebrovasc Endovasc Neurosurg (2012) 0.85
Associations of Moyamoya patients with HLA class I and class II alleles in the Korean population. J Korean Med Sci (2003) 0.85
An update on the diagnosis and treatment of adult Moyamoya disease taking into consideration controversial issues. Neurol Res (2014) 0.85
Adult Moyamoya Disease: A Burden of Intracranial Stenosis in East Asians? PLoS One (2015) 0.84
Circulating Vascular Progenitor Cells in Moyamoya Disease. J Korean Neurosurg Soc (2015) 0.82
Angiographic results of indirect and combined bypass surgery for adult moyamoya disease. J Cerebrovasc Endovasc Neurosurg (2012) 0.81
The natural clinical course of hemodynamically stable adult moyamoya disease. J Neurosurg (2015) 0.80
Feasibility of intravenous flat panel detector CT angiography for intracranial arterial stenosis. AJNR Am J Neuroradiol (2012) 0.80
Contralateral progression and its risk factor in surgically treated unilateral adult moyamoya disease with a review of pertinent literature. Acta Neurochir (Wien) (2013) 0.80
Expression of cellular retinoic acid-binding protein-I (CRABP-I) in the cerebrospinal fluid of adult onset moyamoya disease and its association with clinical presentation and postoperative haemodynamic change. J Neurol Neurosurg Psychiatry (2013) 0.80
Increased prevalence of autoimmune disease in patients with unilateral compared with bilateral moyamoya disease. J Neurosurg (2015) 0.79
NMR-based metabolomics analysis of leptomeningeal carcinomatosis. Neurosurgery (2014) 0.78
Thirteen-year Experience of 44 Patients with Adult Hemorrhagic Moyamoya Disease from a Single Institution: Clinical Analysis by Management Modality. J Cerebrovasc Endovasc Neurosurg (2013) 0.78
The importance of encephalo-myo-synangiosis in surgical revascularization strategies for moyamoya disease in children and adults. World Neurosurg (2015) 0.78
Epidemiology of Moyamoya Disease in Korea: Based on National Health Insurance Service Data. J Korean Neurosurg Soc (2015) 0.78
Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease. J Neurosurg (2015) 0.78
Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia. J Neurosurg (2015) 0.78
Single nucleotide polymorphisms of tissue inhibitor of metalloproteinase genes in familial moyamoya disease. Neurosurgery (2007) 0.77
The Efficacy of Surgical Treatment for the Secondary Prevention of Stroke in Symptomatic Moyamoya Disease: A Meta-Analysis. Medicine (Baltimore) (2015) 0.76
Clinical features of adult moyamoya disease with special reference to the diagnosis. Neurol Med Chir (Tokyo) (2012) 0.76
Perioperative Complications and Long-Term Outcomes After Bypasses in Adults with Moyamoya Disease: A Systematic Review and Meta-Analysis. World Neurosurg (2016) 0.76
Moyamoya Biomarkers. J Korean Neurosurg Soc (2015) 0.76
1H-NMR-based metabolomic analysis of cerebrospinal fluid from adult bilateral moyamoya disease: comparison with unilateral moyamoya disease and atherosclerotic stenosis. Medicine (Baltimore) (2015) 0.76
Effect of stenting on progressive occlusion of small unruptured saccular intracranial aneurysms with residual sac immediately after coil embolization: a propensity score analysis. J Neurointerv Surg (2015) 0.87
Extended monitoring of coiled aneurysms completely occluded at 6-month follow-up: late recanalization rate and related risk factors. Eur Radiol (2016) 0.78
Complex spinal arteriovenous fistula of the craniocervical junction with pial and dural shunts combined with contralateral dural arteriovenous fistula. Interv Neuroradiol (2015) 0.75
Delayed Consecutive Contralateral Thalamic Hemorrhage after Spontaneous Thalamic Hemorrhage. J Cerebrovasc Endovasc Neurosurg (2016) 0.75
Prediction of Prolonged Hemodynamic Instability During Carotid Angioplasty and Stenting. Neurointervention (2016) 0.75
Elevated cellular retinoic Acid binding protein-I in cerebrospinal fluid of patients with hemorrhagic cerebrovascular diseases : preliminary study. J Korean Neurosurg Soc (2015) 0.75
Intra-arterial thrombolysis of central retinal artery occlusion following percutaneous atrial septal defect closure. Catheter Cardiovasc Interv (2015) 0.75